Text Size

Central Blood Volume in Hypotensive Dialysis Patients

This study has been completed.
Sponsor:
Information provided by:
Danish State Hospital
ClinicalTrials.gov Identifier:
NCT00257504
First received: November 21, 2005
Last updated: September 11, 2006
Last verified: September 2006
History of Changes
  Purpose

The purpose of the study is to test whether hypotensive episodes during dialysis - caused by withdrawal of fluid drom the circulation - can be predicted by means of two harmless monitoring techniques.


Condition
Intradialytic Hypotension

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Registration of Central Blood Volume in Hypotensive Dialysis Patients - a Comparison of Thoracic Impedance and Central Venous Saturation Monitoring

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Danish State Hospital:

Estimated Enrollment: 20
Study Start Date: November 2005
Estimated Study Completion Date: May 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Chronic hemodialysis patients with central vascular access

Exclusion Criteria:

  • Patients below 18 years of age
  • Patients unable to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00257504

Locations
Denmark
Danish State Hospital
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Danish State Hospital
Investigators
Study Director: Søren D Ladefoged, MD Danish State Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00257504     History of Changes
Other Study ID Numbers: CBV estimation
Study First Received: November 21, 2005
Last Updated: September 11, 2006
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Hypotension
Vascular Diseases
Cardiovascular Diseases
Antihypertensive Agents
 Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 22, 2013